A critical evaluation of the use of mutagenesis, carcinogenesis, and tumor promotion data in a cancer risk assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin. [electronic resource]
- Regulatory toxicology and pharmacology : RTP Mar 1987
- 57-88 p. digital
Publication Type: Journal Article
0273-2300
10.1016/0273-2300(87)90048-1 doi
Animals Carcinogens Cell Survival--drug effects Dioxins--toxicity Germany, West Humans Intercalating Agents Mutagenicity Tests Mutagens Netherlands Ontario Polychlorinated Dibenzodioxins--metabolism Risk Switzerland United States United States Environmental Protection Agency